Teva issues €1.5B and $3.2B senior notes; proceeds to redeem existing notes

TEVA PHARMACEUTICAL INDUSTRIES LTD

Issued €1.0B 4.250% notes due 2033 and €0.5B 4.625% notes due 2036.
Issued $1.0B 5.500% notes due 2034, $1.0B 5.750% notes due 2037, and $1.2B 5.250% notes due 2032.
Proceeds redeem all 6.750% 2028, 7.875% 2029, 7.375% 2029, and 8.125% 2031 notes; up to $450M of 2027 notes and €1.15B of 2030 notes.
Remaining proceeds for general corporate purposes; notes guaranteed by Teva on senior unsecured basis.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.